While ACTL6A amplification has been linked to increased SWI/SNF chromatin occupancy and YAP activation in HNSCC, the functional consequences of its expression and role as a therapeutic target are not defined. Here, SMARCA1 is linked to head and neck squamous cell carcinoma.